Addition of Market Leading Advisory and Operational Solutions Provider Increases High-Value Offerings and Expands Operational Scale in Key Growth Markets.
Since the GDPR enforcement date, what barriers to compliance are organisations continuing to face, and how are they addressing this?
Learn why requirements for plain-language summaries of clinical studies, aimed at a broad, non-technical audience, could create new risks for sponsors.
Trust is a significant issue in Pharma. Blockchain could solve this problem and more in clinical trials, increasing transparency and saving time.